Clinical Cancer Research CR Surrogrates Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, X. q.
Right arrow Articles by Anker, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, X. q.
Right arrow Articles by Anker, P.
Clinical Cancer Research Vol. 5, 2297-2303, September 1999
© 1999 American Association for Cancer Research


Advances in Brief

Detecting Tumor-related Alterations in Plasma or Serum DNA of Patients Diagnosed with Breast Cancer1

Xu qi Chen, Hervé Bonnefoi, Sophie Diebold-Berger, Jacqueline Lyautey, Christine Lederrey, Ellen Faltin-Traub, Maurice Stroun and Philippe Anker2

Département de Biochimie et de Physiologie Végétale, Faculté des Sciences [X. q. C., J. L., C. L., M. S., P. A.] and Département de Pathologie, Faculté de Médecine [S. D-B.], Université de Genève, and Département de Gynécologie, Hôpital Cantonal Universitaire de Genève [H. B., E. F-T.], 1211 Geneva, Switzerland

Chromosomal abnormalities are associated with the development of breast cancer, and widespread allelic loss or imbalance is frequently found in tumor tissues taken from patients with this disease. Using different markers, we studied a total of 61 patients (divided into three groups) for the presence of microsatellite instability and loss of heterozygosity (LOH) in plasma or serum DNA. Of the initial 27 patients, 35% of the tumor samples displayed LOH, whereas 15% had identical alterations in the corresponding plasma samples. In addition, the adjacent normal breast tissue of two patients also displayed LOH. In a second group of 11 patients, 45% of the tumors displayed LOH, and 27% displayed identical plasma DNA alterations; one case displayed an identical LOH in adjacent nontumor tissue. In a third series of 23 patients also studied with tetranucleotide repeats, 81% of the tumor samples displayed LOH, whereas 48% had LOH in the corresponding serum samples. The fact that small tumors (T1) of histoprognostic grade 1 or in situ carcinomas could present DNA alterations in the plasma/serum at an early stage, allied to the widely increased range of available microsatellite markers, suggests that plasma or serum DNA may become a useful diagnostic tool for early and potentially curable breast cancer.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
H. Schwarzenbach, C. Alix-Panabieres, I. Muller, N. Letang, J.-P. Vendrell, X. Rebillard, and K. Pantel
Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer
Clin. Cancer Res., February 1, 2009; 15(3): 1032 - 1038.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
I. Muller, C. Beeger, C. Alix-Panabieres, X. Rebillard, K. Pantel, and H. Schwarzenbach
Identification of Loss of Heterozygosity on Circulating Free DNA in Peripheral Blood of Prostate Cancer Patients: Potential and Technical Improvements
Clin. Chem., April 1, 2008; 54(4): 688 - 696.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. J. Bastian, G. S. Palapattu, S. Yegnasubramanian, X. Lin, C. G. Rogers, L. A. Mangold, B. Trock, M. Eisenberger, A. W. Partin, and W. G. Nelson
Prognostic Value of Preoperative Serum Cell-Free Circulating DNA in Men with Prostate Cancer Undergoing Radical Prostatectomy
Clin. Cancer Res., September 15, 2007; 13(18): 5361 - 5367.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. K. Pathak, M. Bhutani, S. Kumar, A. Mohan, and R. Guleria
Circulating Cell-Free DNA in Plasma/Serum of Lung Cancer Patients as a Potential Screening and Prognostic Tool
Clin. Chem., October 1, 2006; 52(10): 1833 - 1842.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Hagiwara, L. E. Mechanic, G. E. Trivers, H. L. Cawley, M. Taga, E. D. Bowman, K. Kumamoto, P. He, M. Bernard, S. Doja, et al.
Quantitative Detection of p53 Mutations in Plasma DNA from Tobacco Smokers
Cancer Res., August 15, 2006; 66(16): 8309 - 8317.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
J. Li, L. Harris, H. Mamon, M. H. Kulke, W.-H. Liu, P. Zhu, and G. Mike Makrigiorgos
Whole Genome Amplification of Plasma-Circulating DNA Enables Expanded Screening for Allelic Imbalance in Plasma
J. Mol. Diagn., February 1, 2006; 8(1): 22 - 30.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
M. Woenckhaus, U. Grepmeier, B. Werner, C. Schulz, F. Rockmann, P. J. Wild, G. Rockelein, H. Blaszyk, M. Schuierer, F. Hofstaedter, et al.
Microsatellite Analysis of Pleural Supernatants Could Increase Sensitivity of Pleural Fluid Cytology
J. Mol. Diagn., October 1, 2005; 7(4): 517 - 524.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. Gotoh, H. Hosoi, T. Iehara, Y. Kuwahara, S. Osone, K. Tsuchiya, M. Ohira, A. Nakagawara, H. Kuroda, and T. Sugimoto
Prediction of MYCN Amplification in Neuroblastoma Using Serum DNA and Real-Time Quantitative Polymerase Chain Reaction
J. Clin. Oncol., August 1, 2005; 23(22): 5205 - 5210.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A M Gilbey, D Burnett, R E Coleman, and I Holen
The detection of circulating breast cancer cells in blood
J. Clin. Pathol., September 1, 2004; 57(9): 903 - 911.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
Y.-H. Su, M. Wang, D. E. Brenner, A. Ng, H. Melkonyan, S. Umansky, S. Syngal, and T. M. Block
Human Urine Contains Small, 150 to 250 Nucleotide-Sized, Soluble DNA Derived from the Circulation and May Be Useful in the Detection of Colorectal Cancer
J. Mol. Diagn., May 1, 2004; 6(2): 101 - 107.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Rogers, Y. Joe, T. Manshouri, A. Dey, I. Jilani, F. Giles, E. Estey, E. Freireich, M. Keating, H. Kantarjian, et al.
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia
Blood, April 1, 2004; 103(7): 2799 - 2801.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. El-Hefnawy, S. Raja, L. Kelly, W. L. Bigbee, J. M. Kirkwood, J. D. Luketich, and T. E. Godfrey
Characterization of Amplifiable, Circulating RNA in Plasma and Its Potential as a Tool for Cancer Diagnostics
Clin. Chem., March 1, 2004; 50(3): 564 - 573.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. M. Muller, A. Widschwendter, H. Fiegl, L. Ivarsson, G. Goebel, E. Perkmann, C. Marth, and M. Widschwendter
DNA Methylation in Serum of Breast Cancer Patients: An Independent Prognostic Marker
Cancer Res., November 15, 2003; 63(22): 7641 - 7645.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Stemmer, M. Beau-Faller, E. Pencreac'h, E. Guerin, A. Schneider, D. Jaqmin, E. Quoix, M.-P. Gaub, and P. Oudet
Use of Magnetic Beads for Plasma Cell-free DNA Extraction: Toward Automation of Plasma DNA Analysis for Molecular Diagnostics
Clin. Chem., November 1, 2003; 49(11): 1953 - 1955.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. F. Eisenberger, W. T. Knoefel, M. Peiper, P. Merkert, E. F. Yekebas, P. Scheunemann, K. Steffani, N. H. Stoecklein, S. B. Hosch, and J. R. Izbicki
Squamous Cell Carcinoma of the Esophagus Can Be Detected by Microsatellite Analysis in Tumor and Serum
Clin. Cancer Res., September 15, 2003; 9(11): 4178 - 4183.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Zhu, W. Qin, H. Ehya, J. Lininger, and E. Sauter
Microsatellite Changes in Nipple Aspirate Fluid and Breast Tissue from Women with Breast Carcinoma or Its Precursors
Clin. Cancer Res., August 1, 2003; 9(8): 3029 - 3033.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
B M Ryan, F Lefort, R McManus, J Daly, P W N Keeling, D G Weir, and D Kelleher
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up
Mol. Pathol., June 1, 2003; 56(3): 172 - 179.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Taback, A. E. Giuliano, N. M. Hansen, F. R. Singer, S. Shu, and D. S. B. Hoon
Detection of Tumor-Specific Genetic Alterations in Bone Marrow from Early-Stage Breast Cancer Patients
Cancer Res., April 15, 2003; 63(8): 1884 - 1887.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. H. N. Wong, J. Zhang, P. B. S. Lai, W. Y. Lau, and Y. M. Dennis Lo
Quantitative Analysis of Tumor-derived Methylated p16INK4a Sequences in Plasma, Serum, and Blood Cells of Hepatocellular Carcinoma Patients
Clin. Cancer Res., March 1, 2003; 9(3): 1047 - 1052.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
B M Ryan, F Lefort, R McManus, J Daly, P W N Keeling, D G Weir, and D Kelleher
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up
Gut, January 1, 2003; 52(1): 101 - 108.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. M. Silva, J. Silva, A. Sanchez, J. M. Garcia, G. Dominguez, M. Provencio, L. Sanfrutos, E. Jareno, A. Colas, P. Espana, et al.
Tumor DNA in Plasma at Diagnosis of Breast Cancer Patients Is a Valuable Predictor of Disease-free Survival
Clin. Cancer Res., December 1, 2002; 8(12): 3761 - 3766.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Noura, H. Yamamoto, T. Ohnishi, N. Masuda, T. Matsumoto, O. Takayama, H. Fukunaga, Y. Miyake, M. Ikenaga, M. Ikeda, et al.
Comparative Detection of Lymph Node Micrometastases of Stage II Colorectal Cancer by Reverse Transcriptase Polymerase Chain Reaction and Immunohistochemistry
J. Clin. Oncol., October 15, 2002; 20(20): 4232 - 4241.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. J. Johnson and Y.M. D. Lo
Plasma Nucleic Acids in the Diagnosis and Management of Malignant Disease
Clin. Chem., August 1, 2002; 48(8): 1186 - 1193.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Combaret, C. Audoynaud, I. Iacono, M.-C. Favrot, M. Schell, C. Bergeron, and A. Puisieux
Circulating MYCN DNA as a Tumor-specific Marker in Neuroblastoma Patients
Cancer Res., July 1, 2002; 62(13): 3646 - 3648.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J M Silva, R Rodriguez, J M Garcia, C Munoz, J Silva, G Dominguez, M Provencio, P Espana, and F Bonilla
Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells
Gut, April 1, 2002; 50(4): 530 - 534.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Dominguez, J. Carballido, J. Silva, J. M. Silva, J. M. Garcia, J. Menendez, M. Provencio, P. Espana, and F. Bonilla
p14ARF Promoter Hypermethylation in Plasma DNA as an Indicator of Disease Recurrence in Bladder Cancer Patients
Clin. Cancer Res., April 1, 2002; 8(4): 980 - 985.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
J. M. Silva, J. M. Garcia, G. Dominguez, J. Silva, C. Miralles, B. Cantos, S. Coca, M. Provencio, P. Espana, and F. Bonilla
Persistence of Tumor DNA in Plasma of Breast Cancer Patients After Mastectomy
Ann. Surg. Oncol., January 1, 2002; 9(1): 71 - 76.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. M. Silva, F. Bonilla, H. Blons, F. Coulet, and P. Laurent-Puig
Correspondence re: F. Coulet et al., Detection of Plasma Tumor DNA in Head and Neck Squamous Cell Carcinoma by Microsatellite Typing and p53 Mutation Analysis. Cancer Res., 60: 707-709, 2000.
Cancer Res., December 1, 2001; 61(23): 8595 - 8596.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. M. Silva, G. Dominguez, J. Silva, J. M. Garcia, A. Sanchez, O. Rodriguez, M. Provencio, P. Espana, and F. Bonilla
Detection of Epithelial Messenger RNA in the Plasma of Breast Cancer Patients Is Associated with Poor Prognosis Tumor Characteristics
Clin. Cancer Res., September 1, 2001; 7(9): 2821 - 2825.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Taback, Y. Fujiwara, H.-J. Wang, L. J. Foshag, D. L. Morton, and D. S. B. Hoon
Prognostic Significance of Circulating Microsatellite Markers in the Plasma of Melanoma Patients
Cancer Res., August 1, 2001; 61(15): 5723 - 5726.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Miyake, H. Yamamoto, Y. Fujiwara, M. Ohue, Y. Sugita, N. Tomita, M. Sekimoto, N. Matsuura, H. Shiozaki, and M. Monden
Extensive Micrometastases to Lymph Nodes as a Marker for Rapid Recurrence of Colorectal Cancer: A Study of Lymphatic Mapping
Clin. Cancer Res., May 1, 2001; 7(5): 1350 - 1357.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
X. q. Chen, H. Bonnefoi, M.-F. Pelte, J. Lyautey, C. Lederrey, S. Movarekhi, P. Schaeffer, H. E. Mulcahy, P. Meyer, M. Stroun, et al.
Telomerase RNA as a Detection Marker in the Serum of Breast Cancer Patients
Clin. Cancer Res., October 1, 2000; 6(10): 3823 - 3826.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
J. A. Shaw, B. M. Smith, T. Walsh, S. Johnson, L. Primrose, M. J. Slade, R. A. Walker, and R. C. Coombes
Microsatellite Alterations in Plasma DNA of Primary Breast Cancer Patients
Clin. Cancer Res., March 1, 2000; 6(3): 1119 - 1124.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.